For DLBCL patients, the Risk score = (0.0411) * CXCL9 + (-0.7688) * TIFAB + (0.0489) * C3 + (2.0974) * VCAM1 + (0.5684) * ZBED2 + (1.3951) * TIMD4 + (0.165) * KLHL14 + (-3.1688) * TNFRSF9 + (-0.4584) * FCRL3 + (0.1244) * PLEKHG1. This evidence concerns the gene PLEKHG1 and diffuse large B-cell lymphoma.